Samarth Kulkarni - Chief Executive Officer, Crispr Therapeutics Ag

As of July 1, 2022

What is Samarth Kulkarni's Net Worth?

The current estimated net worth of Crispr Therapeutics Ag's Chief Executive Officer, Samarth Kulkarni, is estimated to be about $34.06M . Samarth Kulkarni owns about 290,279 units of Crispr Therapeutics Ag common stock. In the last 5 years at Crispr Therapeutics Ag, Samarth Kulkarni has sold an estimated value of $27M worth.

What is Samarth Kulkarni's Past Insider Trading?

Samarth Kulkarni's largest purchase order was 30,000 units , worth over $377.1K on August 6, 2021. Samarth Kulkarni's largest sale order was 20,000 units , worth over $4.27M on January 20, 2021. In total, Samarth Kulkarni has made about 47 transactions over 5 years of their time at Crispr Therapeutics Ag. Samarth Kulkarni usually trades in December, with the busiest year in 2021. The most recent transaction was a sale order of 25,000 units , worth over $1.54M on July 1, 2022.

Samarth Kulkarni
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Samarth Kulkarni's' Mailing Address?

  • Mailing address is C/o Crispr Therapeutics Ag 200 Sidney Street Cambridge MA 02139 MA

What are Crispr Therapeutics Ag's Past Insider Trades?

Crispr Therapeutics Ag's most recent insider trade came on July 1, 2022 by Samarth Kulkarni who sold 25,000 units worth $1.54M . In the last 6 years, insiders at Crispr Therapeutics Ag have sold an estimated value of $384.67M and bought an estimated value of $55.38M worth of shares. Insider trading is most common in June, with the busiest year in 2017. The most active traders at the company are Samarth Kulkarni, Chief Executive Officer,  Phd Bradley Bolzon, Director,  and Rodger Novak, President .

CRISPR Therapeutics AG Insider Trades
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1